U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 17:11:40 UTC 2021
Edited
by admin
on Sat Jun 26 17:11:40 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG2A
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
PF8K38CG54
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
FREMANEZUMAB
INN  
USAN   INN  
Official Name English
FREMANEZUMAB [INN]
Common Name English
RN-307
Code English
LBR-101
Code English
IMMUNOGLOBULIN G2, ANTI-(HUMAN .ALPHA.-CALCITONIN GENE-RELATED PEPTIDE/.BETA.-CALCITONIN GENE-RELATED PEPTIDE) (HUMAN-MUS MUSCULUS MONOCLONAL TEV-48125 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TEV-48125 LIGHT CHAIN, DIMER
Systematic Name English
TEV-48125
Code English
FREMANEZUMAB [MI]
Common Name English
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS CALCITONIN GENE-RELATED PEPTIDE 1 (CGRP-I))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.2 HEAVY CHAIN (1-448) (HUMANIZED VH (HOMO SAPIENS IGHV3-7*01 (86%) (IGHD)-IGHJ5*01) (8.10.13) (1-122) -HOMO SAPIENS IGHG2*01 (CH2(A
Systematic Name English
RN307
Code English
LBR101
Code English
TEV48125
Code English
PF-04472429
Code English
FREMANEZUMAB [USAN]
Common Name English
PF04472429
Code English
FREMANEZUMAB [WHO-DD]
Common Name English
Code System Code Type Description
CAS
1655501-53-3
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
NCI_THESAURUS
C174842
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
INN
10299
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
DRUG BANK
DB14041
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
DRUG CENTRAL
5315
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
RXCUI
2056691
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
FDA UNII
PF8K38CG54
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
RXCUI
2056690
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
ALTERNATIVE
MERCK INDEX
M12104
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
LACTMED
Fremanezumab
Created by admin on Sat Jun 26 17:11:40 UTC 2021 , Edited by admin on Sat Jun 26 17:11:40 UTC 2021
PRIMARY
From To
1_22 1_98
1_136 3_214
1_149 1_205
1_224 2_224
1_225 2_225
1_228 2_228
1_231 2_231
1_262 1_322
1_368 1_426
2_22 2_98
2_136 4_214
2_149 2_205
2_262 2_322
2_368 2_426
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_298
N 2_298
Related Record Type Details
TARGET -> INHIBITOR
BINDING
INNOVATOR->PARENT
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL